Related Experiment Video

Updated: Aug 30, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

Agents that stabilise atherosclerotic plaque

Jun R Chiong1, Alan B Miller

  • 1Division of Cardiology, University of Florida Health Science Center, 655 W. 8th Street, Jacksonville, FL 32246, USA. jun.chiong@jax.ufl.edu

Expert Opinion on Investigational Drugs
|October 2, 2003
PubMed

Insights

Plaque stabilization medications reduce adverse coronary events by stabilizing plaques, not just by regressing atherosclerosis. This concept offers a new perspective on treating cardiovascular disease.

Area of Science:

  • Cardiovascular Medicine
  • Atherosclerosis Research

Background:

  • Atherosclerosis involves plaque buildup in arteries.
  • Adverse coronary events are a major health concern.

Purpose of the Study:

  • To explore the concept of plaque stabilization.
  • To understand how medications impact coronary events beyond plaque regression.

Main Methods:

  • Review of existing literature on atherosclerosis.
  • Analysis of imaging modalities used in atherosclerosis studies (e.g., measuring stenosis, plaque volume).
  • Examination of antiatherosclerotic agents and their effects.

Main Results:

  • The concept of plaque stabilization explains how treatments can reduce adverse events.
  • Imaging techniques assess plaque characteristics like stenosis and volume.
  • Various antiatherosclerotic agents have been investigated.

Conclusions:

  • Plaque stabilization offers a comprehensive view of atherosclerosis management.
  • Medical treatment aims to prevent or cure atherosclerosis-related diseases.
  • Further research on antiatherosclerotic agents is ongoing.

More Related Videos

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Inflammation01:38

Inflammation

Overview
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.